Medical Condition News

RSS

Researchers identify new biological pathway that contribute to glaucoma

In a study published today in the Proceedings of the National Academy of Sciences, a team of researchers from the Kennedy Krieger Institute and four collaborating institutions, identified a new and unexpected biological pathway that appears to contribute to the development of glaucoma and its resulting vision loss.

4 Jan 2011

Fondation Leducq awards Penn Medicine researcher $6M grant for cardiovascular disease study

An international team of researchers led by Daniel J. Rader, MD, associate director of Penn Medicine's Institute for Translational Medicine and Therapeutics, has received a $6 million grant from the Paris-based Fondation Leducq to study the molecular genetics of atherosclerotic cardiovascular disease. The team's proposal, "Molecular Mechanisms of Novel Genes Associated with Plasma Lipids and Cardiovascular Disease," was selected to receive the award through the Fondation's Transatlantic Networks of Excellence Program.

4 Jan 2011

Study: Multitude of genes are linked to adult height

As much as 90 percent of variation in adult height may be caused by genetic inheritance, but a multitude of genes are involved. Most of these have yet to be discovered.

4 Jan 2011

New approach to Alzheimer’s care

Protocols and practices at an Arizona nursing home that allows patients with Alzheimer’s disease freedom to eat and sleep when they want makes appears to make them happier and easier to care for, the New York Times reports. Beatitudes, a ministry of the Church of the Beatitude, has also done away with restraints. Each patient is cared for according to his/her individual needs.

3 Jan 2011

Deceptive food labels lead to increased risk of deadly diseases

Did you know that when you pick up a product promoted as trans fat free, you may still be ingesting a significant amount of this potentially harmful substance? An article by Case Western Reserve University School of Medicine student Eric Brandt, published in the January/February 2011 issue of the American Journal of Health Promotion, reveals that misleading labeling practices can result in medically significant intake of harmful trans fat, despite what you read on Food and Drug Administration (FDA) approved labels.

3 Jan 2011

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).

3 Jan 2011

FDA grants orphan drug status for Senesco's SNS01-T in treatment of multiple myeloma

Senesco Technologies, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's lead drug candidate SNS01-T for treatment of multiple myeloma.

3 Jan 2011

FDA clears ACT's IND to treat AMD using hESC derived RPE cells

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to treat Dry Age-Related Macular Degeneration (AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).

3 Jan 2011

Celera seeks FDA premarketing approval for KIF6 Genotyping Assay

Celera Corporation today announced that it has submitted a Premarket Approval Application (PMA) to the U.S. Food and Drug Administration (FDA) for its KIF6 Genotyping Assay, a new molecular In Vitro diagnostic (IVD) test designed to detect a marker for risk of coronary heart disease (CHD) independent of traditional risk factors and aid clinical evaluation when statin treatment is being considered.

3 Jan 2011

Top-line results of TIGER-2 Phase 3 clinical trial for CF treatment

Inspire Pharmaceuticals, Inc. announced today the top-line results from its second Phase 3 clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis.

3 Jan 2011

People magazine features another Dr. Siegal's Cookie Diet success story

For the second time in three years, Dr. Siegal's Cookie Diet success stories are celebrated in People magazine's annual Half Their Size cover story. Marty and Grace Moorehead of Phoenix lost 182 and 51 pounds respectively by following celebrity weight-loss expert Dr. Sanford Siegal's 36 year old weight-loss regimen under the supervision of their own physicians. Marty Moorehead lost half of his 360 pounds and has kept the weight off for a year. The People article is online at http://tinyurl.com/2vl2apk.

3 Jan 2011

Teenage autistic boy allowed sex change procedure

A 16 year old autistic schoolboy has been granted approval to begin treatment for a sex change. He will have the provision to have his sperm frozen in case he decides he wants children. The decision came from Family Court judge Justice Linda Dessau on an emergency application from the boy’s parents so that he can begin therapy before his puberty fully sets in.

30 Dec 2010

New report evaluates rate of reinterventions, readmissions after initial AAA surgery

A new report published in the January issue of the Journal of Vascular Surgery® evaluates the rate of reinterventions and readmissions after initial abdominal aortic aneurysm repair, 30-day mortality and the effect on long-term survival.

30 Dec 2010

Tips to avoid allergy and asthma triggers at the gym

A New Year's resolution to get in shape is good news for your health. But if you have allergies or asthma, the hidden triggers at the gym may be bad for your condition.

30 Dec 2010

Children more likely to suffer from appendicitis in areas with few pediatricians

Children who live in areas with fewer pediatricians are more likely to suffer life-threatening ruptures of the appendix than those in areas with more pediatricians, even when accounting for other factors such as the number of hospitals, imaging technology, insurance coverage and the number of surgeons in an area, according to a study from the Johns Hopkins Children's Center.

30 Dec 2010

Enrollment commences in belinostat-Tarceva combination trial for NSCLC

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, and Topotarget A/S announced today that the first patient has been dosed in an Investigator Initiated Trial of belinostat in combination with Tarceva® for patients with Non-Small Cell Lung Cancer (NSCLC).

30 Dec 2010

Heart researchers find no evidence of toxicity in Longevinex

It was Paracelsus, the Renaissance physician who first said "the dose makes the poison." So, you can drink too much wine, or ingest too much resveratrol, but in an unprecedented study, heart researchers report they couldn't find a toxic dose for Longevinex-, a resveratrol-based dietary supplement.

30 Dec 2010

AngioScore initiates worldwide recall of AngioSculpt PTA Scoring Balloon Catheter

On November 15, 2010 AngioScore Incorporated initiated a worldwide recall of the AngioSculpt® PTA Scoring Balloon Catheter, 0.018" OTW, balloon sizes: 4.0x20mm, 5.0x20mm, and 6.0x20mm. This recall was initiated because of a small number of reports from the field of distal bond failure which has resulted in peeling of the bond and/or detachment of the distal end of the scoring element, wherein the proximal end of the scoring element remains secured to the catheter.

30 Dec 2010

Omega-3 fatty acids may reduce inflammation, disease symptoms and cartilage degeneration

Omega-3 fatty acids from seafood may reduce inflammation, symptoms of gum disease and risk of abnormal heartbeats early after cardiac surgery. One type of omega-3, DHA (docosahexaenoic acid), may also have lasting benefits in visual function for years in children whose mothers consume sufficient prenatal DHA.

30 Dec 2010

Researchers to identify gene variants that cause ischemic stroke

Researchers from the University of Maryland School of Medicine are coordinating an international team of scientists working to identify genes or gene variants that may make a person more likely to have a particular type of stroke called an ischemic stroke.

30 Dec 2010

Medical Condition News

Researchers identify new biological pathway that contribute to glaucoma

Fondation Leducq awards Penn Medicine researcher $6M grant for cardiovascular disease study

Study: Multitude of genes are linked to adult height

New approach to Alzheimer’s care

Deceptive food labels lead to increased risk of deadly diseases

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

FDA grants orphan drug status for Senesco's SNS01-T in treatment of multiple myeloma

FDA clears ACT's IND to treat AMD using hESC derived RPE cells

Celera seeks FDA premarketing approval for KIF6 Genotyping Assay

Top-line results of TIGER-2 Phase 3 clinical trial for CF treatment

People magazine features another Dr. Siegal's Cookie Diet success story

Teenage autistic boy allowed sex change procedure

New report evaluates rate of reinterventions, readmissions after initial AAA surgery

Tips to avoid allergy and asthma triggers at the gym

Children more likely to suffer from appendicitis in areas with few pediatricians

Enrollment commences in belinostat-Tarceva combination trial for NSCLC

Heart researchers find no evidence of toxicity in Longevinex

AngioScore initiates worldwide recall of AngioSculpt PTA Scoring Balloon Catheter

Omega-3 fatty acids may reduce inflammation, disease symptoms and cartilage degeneration

Researchers to identify gene variants that cause ischemic stroke

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Latest News